Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1973-11-3
pubmed:abstractText
Human plasma alpha(2)-macroglobulin is an inhibitor of circulating proteases that function in hemostatic and inflammatory reactions but the biochemical nature of its interaction with these enzymes is not well defined. This investigation has found that alpha(2)-macroglobulin is comprised of subunit chains of 185,000 molecular weight as analyzed by electrophoresis in polyacrylamide gels containing sodium dodecyl sulfate. Trypsin, thrombin, plasmin, and plasma kallikrein in amounts completely bound to alpha(2)-macroglobulin attacked one region in the subunit chain producing a single derivative with a molecular weight of 85,000 indicating that hydrolysis occurred at or near the center of the parent chain. The proteolytic derivative was also identified in an alpha(2)-macroglobulin preparation from plasma incubated with the plasminogen activator, urokinase. alpha(2)-macroglobulin functionally capable of binding enzyme appeared to be required both for limiting tryptic hydrolysis and for confining the concentration dependent increase in the derivative chain to the 1st min of incubation since acid-denatured alpha(2)-macroglobulin that failed to bind trypsin was extensively degraded. Three derivative chains resulted from the interaction of alpha(2)-macroglobulin with chymotrypsin demonstrating the presence of at least two chymotrypsin susceptible regions in the precursor chain. Reduction of the alpha(2)-macroglobulin-enzyme mixture was required for the identification of the derivative subunit chains establishing that these cleavage products were covalently linked to the parent molecule by disulfide bridges. Thus, alpha(2)-inacroglobulin acts as a substrate for circulating proteases, a finding which may also pertain to the mechanism of action of other plasma enzyme inhibitors.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-13625862, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-13664784, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-13848687, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-13905481, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-14163324, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4106393, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4113391, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4122343, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4160504, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4164209, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4166401, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4167390, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4173227, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4238931, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4241814, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4242699, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4244455, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4262568, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4263615, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4264575, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4338122, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4507518, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4557420, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4560419, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4621615, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4971516, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4974623, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-4998094, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5073741, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5101164, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5165598, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5301313, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5806584, http://linkedlifedata.com/resource/pubmed/commentcorrection/4269559-5950769
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
138
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
508-21
pubmed:dateRevised
2010-6-22
pubmed:meshHeading
pubmed:year
1973
pubmed:articleTitle
Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.
pubmed:publicationType
Journal Article